Infusion Parameters of Patients Initiated on Ig20Gly in a Patient Program by Infusion Schedule
HelloCuvitru is a patient program that provides the first 4 infusions of Cuvitru ® (Immune Globulin Subcutaneous [Human], 20% Solution, Ig20Gly) at home and free-of-charge to eligible patients who have primary immunodeficiency diseases (PID). We assessed patient characteristics and infusion parameters by infusion schedules.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Lisa Meckley, Yanyu Wu, Spiros Tzivelekis, Vivek Gandhi, Andre Gladiator Source Type: research
More News: Allergy | Allergy & Immunology | Gammagard Liquid | Primary Immunodeficiency Disease | Privigen